ARIZONA HOUSE OF REPRESENTATIVES Fifty-sixth Legislature First Regular Session
	Senate: COM DPA/SE 6-0-1-0 | 3^rd Read 23-6-1-0 House: COM DP 9-0-0-1 | 3^rd Read 47-12-1-0

---

SB 1052: insurance coverage; biomarker testing

Sponsor: Senator Shope, LD 16

Transmitted to the Governor

Overview

Excludes a policy that provides limited benefit coverage from the requirement that the policy provide coverage for biomarker testing.

History

Contracts for health services, evidence of coverage for health care plans and health insurance policies issued by a hospital or medical service corporations, health care services organization, disability insurer or group or blanket disability insurer are statutorily required to provide coverage for biomarker testing. Biomarker testing is the analysis of a patient's tissue, blood or other biospecimen for the presence of a biomarker. A biomarker is a characteristic that is objectively measured and evaluated as an indicator of normal biological processes, pathogenic processes or pharmacologic responses to a specific therapeutic intervention (A.R.S. §§ 20-841.13, 20-1057.19, 20-1376.10 and 20-1406.10).

Statute defines limited benefit coverage as an insurance policy that is designed, advertised and marketed to supplement major medical insurance and that includes accident only, dental only, vision only, disability income only, fixed or hospital indemnity, specified disease insurance, credit insurance or Taft-Hartley trusts (A.R.S. § 20-1137).

Provisions

1. Specifies a policy that is issued or renewed by a disability insurer, or a group or blanket disability insurer does not include a policy that provides limited benefit coverage. (Sec. 1, 2)

2. Makes a clarifying change. (Sec. 1, 2)

3.

4.

5. ---------- DOCUMENT FOOTER ---------

6.                               SB 1052

7. Initials PRB           Page 0 Transmitted

8.

9. ---------- DOCUMENT FOOTER ---------